Product Purchase Includes: Medication Provider consultation Syringes Alcohol Pads Program guide Administration video Administration and Frequency Available in Subcutaneous (SQ) and Intramuscular (IM) Injections Three times weekly As directed by your prescribing provider Contraindications Compounded Methylcobalamin injections should not be used in individuals who: Have a known hypersensitivity or allergy to cyanocobalamin, methylcobalamin, cobalt, or any component of the formulation Have Leber's disease (hereditary optic nerve atrophy)
Recently, neural activity mediated by NMDA-receptors (NMDAR) has been coupled with transcriptional activation of glutamate-cysteine ligase, a key enzyme in GSH production, leading to a sustained GSH-based protection against an oxidative insult 26
10.3389/fphys.2017.00377 50 ChurchD
Composition: BPC-157 + TB-500 (10 mg total, lyophilized peptide powder) Peptide type: Combination (Pentadecapeptide + Thymosin Beta-4 Fragment) Synonyms: BPC-157 (PL-14736) / TB500 Category: Peptide blend Form: White lyophilized powder in a sealed vial Administration: Subcutaneous research application (requires reconstitution) What is the BPC-157 / TB-500 Blend
FDA-approved medications have extensive clinical trial data from thousands of participants studied over extended periods